お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は、ペット用医薬品の世界市場、容量、生産量、収益、価格の概要を紹介します。2020~2024年の歴史的な市場収益/売上データ、2025年の予想、および2031年までのCAGRの予測を含む世界市場動向の分析。本レポートはメーカー、地域、製品の種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、製品タイプとアプリケーション/端末業界別にペット用医薬品市場を分類しています。
本レポートでは世界のペット用医薬品市場の主な参加者として、企業概要、販売数量、収益、価格、粗利益率、ポートフォリオ、地理的位置、重要な発展を次のパラメータに基づいて紹介します。本研究に含まれる主な企業は：Zoetis、Boehringer Ingelheim、Merck Animal Health、Elanco Animal Health、Virbac、Dechra Veterinary Products、Ceva、Vetoquinol、Meiji、Ouro Fino Saude、Parnell

レポートはペット用医薬品の主要生産者を調査し、主要地域や国の消費状況も提供します。ペット用医薬品の今後の市場の可能性のハイライト、およびこの市場をさまざまなセグメントおよびサブセグメントに予測するための主要な地域/国の焦点。アメリカとカナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、およびその他の国の国別データと市場価値分析。

2020年から2031年までのタイプ別および用途別、売上高、収益、価格別のセグメントデータを分析します。
タイプ別市場セグメント：
    Antiparasitic Drugs
    Antibacterial
    Other

用途別の市場セグメント：
    Dogs
    Cats
    Other

本レポートの詳細内容
本レポートは、世界のペット用医薬品市場の現状と将来展望を包括的に分析し、グローバルの主要地域における開発動向の綿密な調査を通じて、読者に包括的な市場分析を提示するものであります。市場の全体像を把握するために、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいてペット用医薬品市場を細分化しています。この分類と応用により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。
一. 生産面では、2020年から2025年まで、そして2031年までの予測として、メーカー別、地域別（地域レベル、国レベル）のペット用医薬品生産量、成長率、市場シェアを調査している。

二. 消費面では、ペット用医薬品の売上高を地域別（地域レベル・国レベル）、企業別、種類別、用途別に焦点を当てています。2020年から2025年まで、2031年までの予測。

三.主要メーカーのペット用医薬品売上高、収益、市場シェア、業界ランキング、2020年から2025年までのデータに焦点を当てています。世界のペット用医薬品市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。

四.本ペット用医薬品のレポートでは関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立てるのに役立つ洞察を提供することを目的としています。 売上高、成長動向、生産技術、用途、エンドユーザー産業の市場規模に関する詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。

章の概要
第1章：ペット用医薬品のレポート範囲、各市場セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメントのエグゼクティブサマリー（タイプ別およびアプリケーション別など）を紹介します。市場の現状と、短期から中期、および長期的な進化の可能性を高度に見ることができます。（2020～2031）
第2章： ペット用医薬品の世界と主要生産者（地域／国）の生産／アウトプット。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています。（2020～2031）
第3章：世界、地域、国レベルにおけるペット用医薬品の売上（消費）、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界の各国の市場発展、将来の発展の見通し、市場空間を紹介します。（2020～2031）
第4章ペット用医薬品メーカーの競争状況、価格、売上高、収益、市場シェアと業界ランキング、最新の開発計画、合併、買収情報などの詳細分析。（2020～2025）
第5章：ペット用医薬品の各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーした種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2020～2031）
第6章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。（2020～2031）
第7章：北米（米国・カナダ）：タイプ別、用途別、国別、セグメント別の売上高、収益。（2020～2031）
第8章：ヨーロッパ：タイプ別、用途別、国別、セグメント別の売上高と収益。（2020～2031）
第9章：中国：タイプ別、アプリケーション別、セグメント別の売上高、収益。（2020～2031）
第10章：アジア（中国を除く）：タイプ別、用途別、地域別、セグメント別の売上高、収益。（2020～2031）
第11章：中東、アフリカ、中南米：タイプ別、用途別、国別、セグメント別の売上高、収益。（2020～2031）
第12章：ペット用医薬品の主要メーカーの概要を提供し、製品の説明と仕様、ペット用医薬品の売上高、収益、価格、粗利益率、最近の発展など、市場の主要企業の基本的な状況を詳細に紹介します。（2020～2025）
第13章：産業チェーン、販売チャネル、主要原材料、販売代理店および顧客の分析。
第14章：ペット用医薬品の市場動態、市場の最新の動向、市場の推進要因と制約要因、業界内のメーカーが直面する課題とリスク、業界内の関連政策の分析を紹介します。
第15章：レポートの要点と結論。

In this report, we study the Veterinary Products for Pet mainly medicines
Market Analysis and Insights: Global Pet Drug Market
The global Pet Drug market is projected to grow from US$ 13840 million in 2024 to US$ 20540 million by 2030, at a Compound Annual Growth Rate (CAGR) of 6.8% during the forecast period.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 458%.
Report Covers:
This report presents an overview of global market for Pet Drug market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Pet Drug, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Pet Drug, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pet Drug revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Pet Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Pet Drug revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
    Zoetis
    Boehringer Ingelheim
    Merck Animal Health
    Elanco Animal Health
    Virbac
    Dechra Veterinary Products
    Ceva
    Vetoquinol
    Meiji
    Ouro Fino Saude
    Parnell

Segment by Type
    Antiparasitic Drugs
    Antibacterial
    Other

Segment by Application
    Dogs
    Cats
    Other

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Pet Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pet Drug companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pet Drug revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
    Table 1. Global Pet Drug Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Antiparasitic Drugs
    Table 3. Key Players of Antibacterial
    Table 4. Key Players of Other
    Table 5. Global Pet Drug Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 6. Global Pet Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Pet Drug Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global Pet Drug Market Share by Region (2019-2024)
    Table 9. Global Pet Drug Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global Pet Drug Market Share by Region (2025-2030)
    Table 11. Pet Drug Market Trends
    Table 12. Pet Drug Market Drivers
    Table 13. Pet Drug Market Challenges
    Table 14. Pet Drug Market Restraints
    Table 15. Global Pet Drug Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global Pet Drug Revenue Share by Players (2019-2024)
    Table 17. Global Top Pet Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Drug as of 2023)
    Table 18. Global Pet Drug Industry Ranking 2022 VS 2023 VS 2024
    Table 19. Global 5 Largest Players Market Share by Pet Drug Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Global Key Players of Pet Drug, Headquarters and Area Served
    Table 21. Global Key Players of Pet Drug, Product and Application
    Table 22. Global Key Players of Pet Drug, Product and Application
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Pet Drug Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global Pet Drug Revenue Market Share by Type (2019-2024)
    Table 26. Global Pet Drug Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global Pet Drug Revenue Market Share by Type (2025-2030)
    Table 28. Global Pet Drug Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global Pet Drug Revenue Share by Application (2019-2024)
    Table 30. Global Pet Drug Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global Pet Drug Revenue Share by Application (2025-2030)
    Table 32. North America Pet Drug Market Size by Type (2019-2024) & (US$ Million)
    Table 33. North America Pet Drug Market Size by Type (2025-2030) & (US$ Million)
    Table 34. North America Pet Drug Market Size by Application (2019-2024) & (US$ Million)
    Table 35. North America Pet Drug Market Size by Application (2025-2030) & (US$ Million)
    Table 36. North America Pet Drug Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. North America Pet Drug Market Size by Country (2019-2024) & (US$ Million)
    Table 38. North America Pet Drug Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Europe Pet Drug Market Size by Type (2019-2024) & (US$ Million)
    Table 40. Europe Pet Drug Market Size by Type (2025-2030) & (US$ Million)
    Table 41. Europe Pet Drug Market Size by Application (2019-2024) & (US$ Million)
    Table 42. Europe Pet Drug Market Size by Application (2025-2030) & (US$ Million)
    Table 43. Europe Pet Drug Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Europe Pet Drug Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Europe Pet Drug Market Size by Country (2025-2030) & (US$ Million)
    Table 46. China Pet Drug Market Size by Type (2019-2024) & (US$ Million)
    Table 47. China Pet Drug Market Size by Type (2025-2030) & (US$ Million)
    Table 48. China Pet Drug Market Size by Application (2019-2024) & (US$ Million)
    Table 49. China Pet Drug Market Size by Application (2025-2030) & (US$ Million)
    Table 50. Asia Pet Drug Market Size by Type (2019-2024) & (US$ Million)
    Table 51. Asia Pet Drug Market Size by Type (2025-2030) & (US$ Million)
    Table 52. Asia Pet Drug Market Size by Application (2019-2024) & (US$ Million)
    Table 53. Asia Pet Drug Market Size by Application (2025-2030) & (US$ Million)
    Table 54. Asia Pet Drug Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 55. Asia Pet Drug Market Size by Region (2019-2024) & (US$ Million)
    Table 56. Asia Pet Drug Market Size by Region (2025-2030) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Pet Drug Market Size by Type (2019-2024) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Pet Drug Market Size by Type (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Pet Drug Market Size by Application (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Pet Drug Market Size by Application (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Pet Drug Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 62. Middle East, Africa, and Latin America Pet Drug Market Size by Country (2019-2024) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Pet Drug Market Size by Country (2025-2030) & (US$ Million)
    Table 64. Zoetis Company Details
    Table 65. Zoetis Business Overview
    Table 66. Zoetis Pet Drug Product
    Table 67. Zoetis Revenue in Pet Drug Business (2019-2024) & (US$ Million)
    Table 68. Zoetis Recent Developments
    Table 69. Boehringer Ingelheim Company Details
    Table 70. Boehringer Ingelheim Business Overview
    Table 71. Boehringer Ingelheim Pet Drug Product
    Table 72. Boehringer Ingelheim Revenue in Pet Drug Business (2019-2024) & (US$ Million)
    Table 73. Boehringer Ingelheim Recent Developments
    Table 74. Merck Animal Health Company Details
    Table 75. Merck Animal Health Business Overview
    Table 76. Merck Animal Health Pet Drug Product
    Table 77. Merck Animal Health Revenue in Pet Drug Business (2019-2024) & (US$ Million)
    Table 78. Merck Animal Health Recent Developments
    Table 79. Elanco Animal Health Company Details
    Table 80. Elanco Animal Health Business Overview
    Table 81. Elanco Animal Health Pet Drug Product
    Table 82. Elanco Animal Health Revenue in Pet Drug Business (2019-2024) & (US$ Million)
    Table 83. Elanco Animal Health Recent Developments
    Table 84. Virbac Company Details
    Table 85. Virbac Business Overview
    Table 86. Virbac Pet Drug Product
    Table 87. Virbac Revenue in Pet Drug Business (2019-2024) & (US$ Million)
    Table 88. Virbac Recent Developments
    Table 89. Dechra Veterinary Products Company Details
    Table 90. Dechra Veterinary Products Business Overview
    Table 91. Dechra Veterinary Products Pet Drug Product
    Table 92. Dechra Veterinary Products Revenue in Pet Drug Business (2019-2024) & (US$ Million)
    Table 93. Dechra Veterinary Products Recent Developments
    Table 94. Ceva Company Details
    Table 95. Ceva Business Overview
    Table 96. Ceva Pet Drug Product
    Table 97. Ceva Revenue in Pet Drug Business (2019-2024) & (US$ Million)
    Table 98. Ceva Recent Developments
    Table 99. Vetoquinol Company Details
    Table 100. Vetoquinol Business Overview
    Table 101. Vetoquinol Pet Drug Product
    Table 102. Vetoquinol Revenue in Pet Drug Business (2019-2024) & (US$ Million)
    Table 103. Vetoquinol Recent Developments
    Table 104. Meiji Company Details
    Table 105. Meiji Business Overview
    Table 106. Meiji Pet Drug Product
    Table 107. Meiji Revenue in Pet Drug Business (2019-2024) & (US$ Million)
    Table 108. Meiji Recent Developments
    Table 109. Ouro Fino Saude Company Details
    Table 110. Ouro Fino Saude Business Overview
    Table 111. Ouro Fino Saude Pet Drug Product
    Table 112. Ouro Fino Saude Revenue in Pet Drug Business (2019-2024) & (US$ Million)
    Table 113. Ouro Fino Saude Recent Developments
    Table 114. Parnell Company Details
    Table 115. Parnell Business Overview
    Table 116. Parnell Pet Drug Product
    Table 117. Parnell Revenue in Pet Drug Business (2019-2024) & (US$ Million)
    Table 118. Parnell Recent Developments
    Table 119. Research Programs/Design for This Report
    Table 120. Key Data Information from Secondary Sources
    Table 121. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Pet Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Pet Drug Market Share by Type: 2023 VS 2030
    Figure 3. Antiparasitic Drugs Features
    Figure 4. Antibacterial Features
    Figure 5. Other Features
    Figure 6. Global Pet Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Pet Drug Market Share by Application: 2023 VS 2030
    Figure 8. Dogs Case Studies
    Figure 9. Cats Case Studies
    Figure 10. Other Case Studies
    Figure 11. Pet Drug Report Years Considered
    Figure 12. Global Pet Drug Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 13. Global Pet Drug Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Pet Drug Market Share by Region: 2023 VS 2030
    Figure 15. Global Pet Drug Market Share by Players in 2023
    Figure 16. Global Top Pet Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Drug as of 2023)
    Figure 17. The Top 10 and 5 Players Market Share by Pet Drug Revenue in 2023
    Figure 18. North America Pet Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 19. North America Pet Drug Market Share by Type (2019-2030)
    Figure 20. North America Pet Drug Market Share by Application (2019-2030)
    Figure 21. North America Pet Drug Market Share by Country (2019-2030)
    Figure 22. United States Pet Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Canada Pet Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Europe Pet Drug Market Size YoY (2019-2030) & (US$ Million)
    Figure 25. Europe Pet Drug Market Share by Type (2019-2030)
    Figure 26. Europe Pet Drug Market Share by Application (2019-2030)
    Figure 27. Europe Pet Drug Market Share by Country (2019-2030)
    Figure 28. Germany Pet Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. France Pet Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. U.K. Pet Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Italy Pet Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Russia Pet Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Nordic Countries Pet Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. China Pet Drug Market Size YoY (2019-2030) & (US$ Million)
    Figure 35. China Pet Drug Market Share by Type (2019-2030)
    Figure 36. China Pet Drug Market Share by Application (2019-2030)
    Figure 37. Asia Pet Drug Market Size YoY (2019-2030) & (US$ Million)
    Figure 38. Asia Pet Drug Market Share by Type (2019-2030)
    Figure 39. Asia Pet Drug Market Share by Application (2019-2030)
    Figure 40. Asia Pet Drug Market Share by Region (2019-2030)
    Figure 41. Japan Pet Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. South Korea Pet Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. China Taiwan Pet Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia Pet Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. India Pet Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Australia Pet Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Middle East, Africa, and Latin America Pet Drug Market Size YoY (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Pet Drug Market Share by Type (2019-2030)
    Figure 49. Middle East, Africa, and Latin America Pet Drug Market Share by Application (2019-2030)
    Figure 50. Middle East, Africa, and Latin America Pet Drug Market Share by Country (2019-2030)
    Figure 51. Brazil Pet Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Mexico Pet Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Turkey Pet Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Saudi Arabia Pet Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Israel Pet Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. GCC Countries Pet Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Zoetis Revenue Growth Rate in Pet Drug Business (2019-2024)
    Figure 58. Boehringer Ingelheim Revenue Growth Rate in Pet Drug Business (2019-2024)
    Figure 59. Merck Animal Health Revenue Growth Rate in Pet Drug Business (2019-2024)
    Figure 60. Elanco Animal Health Revenue Growth Rate in Pet Drug Business (2019-2024)
    Figure 61. Virbac Revenue Growth Rate in Pet Drug Business (2019-2024)
    Figure 62. Dechra Veterinary Products Revenue Growth Rate in Pet Drug Business (2019-2024)
    Figure 63. Ceva Revenue Growth Rate in Pet Drug Business (2019-2024)
    Figure 64. Vetoquinol Revenue Growth Rate in Pet Drug Business (2019-2024)
    Figure 65. Meiji Revenue Growth Rate in Pet Drug Business (2019-2024)
    Figure 66. Ouro Fino Saude Revenue Growth Rate in Pet Drug Business (2019-2024)
    Figure 67. Parnell Revenue Growth Rate in Pet Drug Business (2019-2024)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed